ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Simcere Pharmaceutical Group Ltd. ?
1
Poor long term growth as Operating profit has grown by an annual rate 4.39% of over the last 5 years
2
Flat results in Jun 25
- INTEREST(HY) At HKD 52.13 MM has Grown at 105%
- DEBT-EQUITY RATIO (HY) Highest at -5.15 %
3
With ROE of 10.60%, it has a Very Expensive valuation with a 4.67 Price to Book Value
- Over the past year, while the stock has generated a return of 63.88%, its profits have fallen by -13.4%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Simcere Pharmaceutical Group Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Simcere Pharmaceutical Group Ltd.
63.88%
2.19
57.68%
Hang Seng Hong Kong
8.25%
0.41
19.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.74%
EBIT Growth (5y)
4.39%
EBIT to Interest (avg)
9.10
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.71
Tax Ratio
10.61%
Dividend Payout Ratio
55.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.17%
ROE (avg)
13.53%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
44
Industry P/E
Price to Book Value
4.67
EV to EBIT
35.67
EV to EBITDA
25.82
EV to Capital Employed
5.15
EV to Sales
4.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.45%
ROE (Latest)
10.60%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 3,092.49 MM
RAW MATERIAL COST(Y)
Fallen by -6.66% (YoY
NET SALES(Q)
Highest at HKD 3,850.74 MM
OPERATING PROFIT(Q)
Highest at HKD 882.73 MM
OPERATING PROFIT MARGIN(Q)
Highest at 22.92 %
-5What is not working for the Company
INTEREST(HY)
At HKD 52.13 MM has Grown at 105%
DEBT-EQUITY RATIO
(HY)
Highest at -5.15 %
Here's what is working for Simcere Pharmaceutical Group Ltd.
Operating Cash Flow
Highest at HKD 3,092.49 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Sales
Highest at HKD 3,850.74 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Operating Profit
Highest at HKD 882.73 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Operating Profit Margin
Highest at 22.92 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by -6.66% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Simcere Pharmaceutical Group Ltd.
Interest
At HKD 52.13 MM has Grown at 105%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Debt-Equity Ratio
Highest at -5.15 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
